glp-1 west valley city Utah Overcome GLP-1 Side Effects with

Xu Q, et al

Tirzepatide also has excellent efficacy

is supported by the Austrian Science Fund (FWF P33070)

The first drug targeting the GLP-1 receptor was exenatide, released in 2005 as a twice-daily injection to treat type II diabetes

Alnylam and Inceptive have reached a strategic AI collaboration to accelerate the development of RNAi therapy On June 3, 2026, Alnylam Pharmaceuticals (NASDAQ: ALNY) and lnceptive Nucleics, a company dedicated to building life science foundation models, announced today that they have signed a strategic partnership agreement aimed at accelerating the development of innovative therapeutic drugs

Abbreviations ACEI: angiotensin-converting enzyme inhibitors AHAs: anti-hyperglycemic agents Ang II: angiotensin II ARBs: angiotensin receptor blockers BP: blood pressure BUN: blood urea nitrogen CI: confidence interval CV: cardiovascular DKD: diabetic kidney disease DPP-4: dipeptidyl peptidase-4 eGFR: estimated glomerular filtration rate EGP: endogenous glucose production FPG: fasting plasma glucose GFR: glomerular filtration rate GLP-1: glucagon-like peptide-1 GLP1-RAs: glucagon-like peptide-1 receptor agonists HbA1c: glycated haemoglobin HDL-C: high density lipoprotein-cholesterol HF: heart failure HGP: hepatic glucose production LDL-C: low density lipoprotein-cholesterol MACE: major adverse cardiovascular events MRAs: mineralocorticoid receptor antagonists NF-kB: nuclear factor kappa B OLETF: Otsuka Long-Evans Tokushima Fatty PK-PD: pharmokinetics and pharmacodynamic RAAS: reninangiotensinaldosterone system RAS: reninangiotensin system RCT: randomized controlled trial SBP: systolic blood pressure SGLT2: sodiumglucose co-transporter 2 STZ: streptozocin T2DM: type 2 diabetes mellitus UACR: urine albumincreatinine ratio UGE: urinary glucose excretion References Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al